PubMedCentralPubMedCrossRef 38 Mokracka J, Koczura R, Kaznowski

PubMedCentralPubMedCrossRef 38. Mokracka J, Koczura R, Kaznowski A: Multiresistant Enterobacteriaceae with class 1 and class 2 integrons in a municipal wastewater treatment plant. Water Res 2012, 46:3353–3363.PubMedCrossRef 39. Coque TM, Oliver A, Pérez-Díaz JC, Baquero F, Cantón R: Genes Encoding TEM-4, SHV-2, and CTX-M-10 Extended-Spectrum β-Lactamases Are Carried by Multiple Klebsiella pneumoniae Clones in a Single Hospital (Madrid, 1989 to 2000). Lazertinib cell line Antimicrob Agents Chemother 2002, 46:500–510.PubMedCentralPubMedCrossRef 40. Paterson DL, Hujer KM, Hujer AM, Yeiser B, Bonomo MD, Rice LB, Bonomo

RA: Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV-and CTX-M-type β-lactamases. Antimicrob Agents Chemother 2003, 47:3554–3560.PubMedCentralPubMedCrossRef 41. Heritage J, M’Zali FH, Gascoyne-Binzi D, Hawkey PM: Evolution and spread of SHV extended-spectrum β-lactamases in Gram-negative bacteria. Journal of MK-8776 clinical trial antimicrobial chemotherapy 1999, 44:309–318.PubMedCrossRef 42. Babini GS, Livermore DM: Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in

1997–1998. J Antimicrob Chemother 2000, 45:183–189.PubMedCrossRef 43. Pitout J, Sanders C, Sanders W Jr: Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli. Am J Med 1997, 103:51–59.PubMedCrossRef 44. Bonnet R: Growing group of extended-spectrum

β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004, 48:1–14.PubMedCentralPubMedCrossRef 45. Pitout JDD, Laupland KB: Extended-spectrum [beta]-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159–166.PubMedCrossRef 46. Coque T, Baquero F, Canton R: Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveillance 2008, 13:19–29. 47. CDC: Antibiotic resistance threats in the United States. 2013. 48. Boyd DA, Tyler S, Christianson S, McGeer A, Muller MP, Willey BM, Bryce E, Gardam M, Nordmann P, Mulvey MR: Complete nucleotide sequence of a 92-kilobase plasmid harboring the Avelestat (AZD9668) CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother 2004, 48:3758–3764.PubMedCentralPubMedCrossRef 49. Lavollay M, Mamlouk K, Frank T, Akpabie A, Burghoffer B, Redjeb SB, Bercion R, Gautier V, Arlet G: Clonal dissemination of a CTX-M-15 β-lactamase-producing Escherichia coli strain in the Paris area, Tunis, and Bangui. Antimicrob Agents Chemother 2006, 50:2433–2438.PubMedCentralPubMedCrossRef 50. Cho YJ, Moon DC, Jin JS, Choi CH, Lee YC, Lee JC: Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals. Diagn Microbiol Infect Dis 2009, 64:185–190.PubMedCrossRef 51.

Comments are closed.